Thanks for posting this intel. That's a very interesting transaction here with ETBI.
Maybe... just maybe... such a deal was consummated because of the belief that something is known to exist that justifies buying ETBI later at .05 per share of which will be considered at a discount and not at a premium at such time. I think having an insulin pill to take that will eliminate taking the insulin shot for people with diabetes could be something huge for ETBI and any Big Pharma that wants in:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.